Growth Metrics

Usana Health Sciences (USNA) Total Non-Current Liabilities (2016 - 2026)

Usana Health Sciences has reported Total Non-Current Liabilities over the past 16 years, most recently at $122.3 million for Q2 2026.

  • Quarterly Total Non-Current Liabilities fell 13.99% to $122.3 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $122.3 million through Apr 2026, down 13.99% year-over-year, with the annual reading at $133.5 million for FY2026, 7.13% down from the prior year.
  • Total Non-Current Liabilities was $122.3 million for Q2 2026 at Usana Health Sciences, down from $133.5 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $169.4 million in Q2 2022 and troughed at $108.5 million in Q2 2024.
  • The 5-year median for Total Non-Current Liabilities is $128.5 million (2022), against an average of $132.6 million.
  • Year-over-year, Total Non-Current Liabilities decreased 21.2% in 2022 and then increased 20.76% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $147.9 million in 2022, then fell by 16.57% to $123.4 million in 2023, then increased by 16.45% to $143.7 million in 2024, then fell by 14.31% to $123.1 million in 2025, then decreased by 0.68% to $122.3 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Total Non-Current Liabilities are $122.3 million (Q2 2026), $133.5 million (Q1 2026), and $123.1 million (Q3 2025).